Dr Gary P. Moss

Title: Senior Lecturer in Pharmaceutics
Phone: 01782 734776
Email: g.p.j.moss@keele.ac.uk
Location: Hornbeam Building, Room 1.16
Role: Director of Studies, BSc Pharmaceutical Science, Technology & Business
Lead for Pharmaceutics
Undergraduate Electives co-ordinator
Early Resolution Office (Undergraduate)
Contacting me: Please arrange appointments via email.
Gary Moss

I obtained my BSc, MSc and PhD degrees at the Queen’s University of Belfast. I have worked in industry, for Unilever Research, and have also held a number of academic posts prior to joining Keele. I joined the Keele University School of Pharmacy in January 2010 where I am currently Director of Studies for the BSc Pharmaceutical Science, Technology & Business degree programme, subject lead for pharmaceutics and the School’s Early Resolution Officer (undergraduate).

My main research interests are in percutaneous absorption, particularly in the development of quantitative models of skin absorption, the percutaneous absorption of metals and the use of skin imaging techniques to understand the mechanism of skin permeation enhancement. Recent key achievements include:

-       organisation of the EPSRC POEMS-network-funded meeting on modelling of skin absorption at Keele Hall (Jan. 2017)

-       Publication of a book on Mathematical Modelling of Percutaneous Absorption; Springer, 2015

-       Member of the Scientific Organising Committee, Perspectives in Percutaneous Penetration Conference; Invited speaker and session chair, 2012 and 2014.

-       Invited speaker and co-organiser of the 8th meeting of the International Society of the Stratum Corneum, Cardiff, September 2014; deputy chair and treasurer of this group.

-       Invited keynote speaker at the Karolinska Institute’s First International Conference on Modelling Dermal Absorption, Beijing, People’s Republic of China, September 2013. 

-       Participant in the Royal Society’s MP-Scientist pairing scheme, November 2012, and follow-up alumni event, November 2013.

Selected Publications

  • Holmes AM, Scurr DJ, Heylings JR, Wan K-W, Moss GP. 2017. Dendrimer pre-treatment enhances the skin permeation of chlorhexidine digluconate: Characterisation by in vitro percutaneous absorption studies and Time-of-Flight Secondary Ion Mass Spectrometry. Eur J Pharm Sci, vol. 104, 90-101. link> doi>
  • Shah P, White S, Moss G, Ratcliffe N. 2016. Pharmacy students’ views on community pharmacy provision of first aid and responding to medical emergencies: a scenario-based questionnaire studys. International Journal of Pharmacy Practice (vol. 24 (Suppl 3), p. 19). Pharmaceutical Press.
  • Moss GPJ. 2016. Support vector regression to estimate the permeability enhancement of potential transdermal enhancers. Journal of Pharmacy and Pharmacology. doi>
  • Moss G, Gullick D, Wilkinson S. 2015. Predictive Methods in Percutaneous Absorption. Springer.
  • Ashrafi P, Moss GPJ, Wilkinson SC, Davey N, Sun Y. 2015. The application of machine learning to the modelling of percutaneous absorption: An overview and guide. SAR and QSAR in Environmental Research, vol. 26(3), 181-204. doi> link>

Full Publications List show

Books

  • Moss G, Gullick D, Wilkinson S. 2015. Predictive Methods in Percutaneous Absorption. Springer.

Journal Articles

  • Holmes AM, Scurr DJ, Heylings JR, Wan K-W, Moss GP. 2017. Dendrimer pre-treatment enhances the skin permeation of chlorhexidine digluconate: Characterisation by in vitro percutaneous absorption studies and Time-of-Flight Secondary Ion Mass Spectrometry. Eur J Pharm Sci, vol. 104, 90-101. link> doi>
  • Moss GPJ. 2016. Support vector regression to estimate the permeability enhancement of potential transdermal enhancers. Journal of Pharmacy and Pharmacology. doi>
  • Ashrafi P, Moss GPJ, Wilkinson SC, Davey N, Sun Y. 2015. The application of machine learning to the modelling of percutaneous absorption: An overview and guide. SAR and QSAR in Environmental Research, vol. 26(3), 181-204. doi> link>
  • Richardson A, Curtis ADM, Moss GP, Pearson RJ, White S, Rutten FJM, Perumal D, Maddock K. 2014. Simulated drug discovery process to conduct a synoptic assessment of pharmacy students. Am J Pharm Educ, vol. 78(2), 41. link> doi>
  • Judd AM, Scurr DJ, Heylings JR, Wan K-W, Moss GP. 2013. Distribution and visualisation of chlorhexidine within the skin using ToF-SIMS: a potential platform for the design of more efficacious skin antiseptic formulations. Pharm Res, vol. 30(7), 1896-1905. link> doi>
  • Moss GP. 2013. The contributions of the Celtic masters and their associates. Skin Pharmacol Physiol, vol. 26(4-6), 343-355. link> doi>
  • Moss GP, Wilkinson SC, Sun Y. 2012. Mathematical modelling of percutaneous absorption. CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, vol. 17(3), 166-172. link> doi>
  • Brown MB, Lau C-H, Lim ST, Sun Y, Davey N, Moss GP, Yoo S-H, De Muynck C. 2012. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption. J Pharm Pharmacol, vol. 64(4), 566-577. link> doi>
  • Moss GP, Shah AJ, Adams RG, Davey N, Wilkinson SC, Pugh WJ, Sun Y. 2012. The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers. Eur J Pharm Sci, vol. 45(1-2), 116-127. link> doi>
  • Moss GP, Sun Y, Wilkinson SC, Davey N, Adams R, Martin GP, Prapopopolou M, Brown MB. 2011. The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranes. J Pharm Pharmacol, vol. 63(11), 1411-1427. link> doi>
  • Sun Y, Brown MB, Prapopoulou M, Davey N, Adams RG, Moss GP. 2011. The application of stochastic machine learning methods in the prediction of skin penetration. APPLIED SOFT COMPUTING, vol. 11(2), 2367-2375. link> doi>
  • Lam LT, Sun Y, Davey N, Adams R, Prapopoulou M, Brown MB, Moss GP. 2010. The application of feature selection to the development of Gaussian process models for percutaneous absorption. J Pharm Pharmacol, vol. 62(6), 738-749. link> doi>
  • Sun Y, Brown MB, Prapodopolou M, Adams R, Davey N, Moss GP. 2010. The application of Gaussian Processes in the prediction of absorption across mammalian sin and synthetic membranes.
  • Jones DS and Moss GP. 2010. Themed issue: Recent advances in transdermal drug delivery. JOURNAL OF PHARMACY AND PHARMACOLOGY, vol. 62(6), 669-670. link> doi>
  • Gullick DR, Pugh WJ, Ingram MJ, Cox PA, Moss GP. 2010. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption. Drug Dev Ind Pharm, vol. 36(8), 926-932. link> doi>
  • Moss GP, Sun Y, Prapopoulou M, Davey N, Adams R, Pugh WJ, Brown MB. 2009. The application of Gaussian processes in the prediction of percutaneous absorption. J Pharm Pharmacol, vol. 61(9), 1147-1153. link> doi>
  • Gullick DR, Ingram MJ, Pugh WJ, Cox PA, Gard P, Smart JD, Moss GP. 2009. Metabolism of captopril carboxyl ester derivatives for percutaneous absorption. J Pharm Pharmacol, vol. 61(2), 159-165. link> doi>
  • Reid ML, Brown MB, Moss GP, Jones SA. 2008. An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes. J Pharm Pharmacol, vol. 60(9), 1139-1147. link> doi>
  • Long AJ, Pugh WJ, Ingram MJ, Haigh S, Moss GP. 2008. The effect of language background on teaching and learning on the M.Pharm. Pharmacy Eduction, vol. 8(1), 45-52.
  • Long AJ, Pugh WJ, Ingram MJ, Haigh S, Moss GP. 2008. The effect of language background to teaching and learning on the M.Pharm. Pharmacy Education, vol. 8, 45-52.
  • Moss GP. 2007. Cosmetic claims: getting under your skin. The Biochemist, vol. 29, 8-10.
  • Ingram MJ, Sagoe LA, Sosabowski MH, Lond AJ, Moss GP. 2007. Pharmacy student perceptions of educational media tools. Pharmacy Eduction, vol. 7(1), 77-82. doi>
  • Hynam GM, Zeller E, Moss GP, Hall CE. 2006. A potential anti-implantation and spermicidal strategy: Putative derivatives of nonoxynol-9 and anti-inflammatory agents and their spermicidal activity. European Journal of Contraception and Reproductive Healthcare, vol. 11, 258-261. doi>
  • Heard CM, Johnson S, Moss G, Thomas CP. 2006. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana. Int J Pharm, vol. 317(1), 26-31. link> doi>
  • Moss GP, Gullick DR, Cox PA, Alexander C, Ingram MJ, Smart JD, Pugh WJ. 2006. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption. J Pharm Pharmacol, vol. 58(2), 167-177. link> doi>
  • Moss GP, Gullick DR, Woolfson AD, McCafferty DF. 2006. Mechanical characterization and drug permeation properties of tetracaine-loaded bioadhesive films for percutaneous local anesthesia. Drug Dev Ind Pharm, vol. 32(2), 163-174. link> doi>
  • Pugh WJ, Wong R, Falson F, Michniak BB, Moss GP. 2005. Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers. J Pharm Pharmacol, vol. 57(11), 1389-1396. link> doi>
  • Moss GP, Gullick DR, Pugh WJ. 2005. Multiple-application dosing: effect on the percutaneous absorptionof aluminium from commercially available products. J Pharmacy & Pharmacology, vol. 57s, 104.
  • Ingram MJ, Gard P, Gale G, Moss GP, Gullick DR. 2005. Synthesis and in vitro v vascular response of a putative captopril methyl ester nitric oxide releasing prodrug, on aortic helical strips. J Pharmacy & Pharmacology, vol. 57s((British Pharmaceutical Conference, Manchester)), 79.
  • Dennis AC, McGarvey JJ, Woolfson AD, McCafferty DF, Moss GP. 2004. A Raman spectroscopic investigation of bioadhesive tetracaine local anaesthetic formulations. Int J Pharm, vol. 279(1-2), 43-50. link> doi>
  • Ingram MJ, Edmonds H, Moss GP, Long AJ, Sosabowski MH, McLennan MW. 2004. The role of handouts in the MPharm degree pathway - differentiation between the inquisitive and acquisitive. Pharmacy Eduction, vol. 4(1), 7-12.
  • Ingram MJ, Gard P, Patel N, Moss GP, Gullick DR. 2004. ACE-inhibitory activity of captopril methyl ester prodrug. J Pharmacy & Pharmacology, vol. 56s((British Pharmaceutical Conference, Manchester)), 88.
  • Moss GP. 2004. Prodrugs for enhanced percutaneous absorption. J Pharmacy & Pharmacology, vol. 56s((British Pharmaceutical Conference, Manchester)), 100.
  • Moss GP, Dibben SD, Gullick DR, Thomas SK, Pugh WJ. 2004. The in vitro percutaneous absorption of aluminium from topical products. J Pharmacy & Pharmacology, vol. 56s((British Pharmaceutical Conference, Manchester)), 68.
  • Jarvis C, Beveridge J, Heard CM, McGuigan C, Moss GP. 2003. Characteristics of the percutaneous penetration of novel anti-varcella zoster virus nucleoside analogues by confocal laser scanning microscopy. J Pharmacy & Pharmacology, vol. 56S(British Pharmaceutical Conference, Harrogate, UK), 25.
  • Moss GP, Dennis AC, McGarvey JJ, Woolfson AD, McCafferty DF. 2003. Surface-enhanced Raman spectroscopy if tetracaine deposition in the stratum corneum. J Pharmacy & Pharmacology, vol. 56S(British Pharmaceutical Confernce), 29.
  • Moss GP, Sun Y, Davey N, Wilkinson SC, Brown MB. 2015. Linear or non-linear models for percutaneous absorption?. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, vol. 37(1), 144. link>

Chapters

  • Garnier T and Moss GP. 2009. Skin case studies. In Clinical case studies in pharmacy. Dhillon S and Raymond R (Eds.). London: Pharmaceutical Press.

Other

  • Shah P, White S, Moss G, Ratcliffe N. 2016. Pharmacy students’ views on community pharmacy provision of first aid and responding to medical emergencies: a scenario-based questionnaire studys. International Journal of Pharmacy Practice (vol. 24 (Suppl 3), p. 19). Pharmaceutical Press.
  • Judd AM, Moss GP, Heylings J, Wan K-W, Yang Y. 2013. Optical Coherence Tomography to delineate the interactions of PAMAM dendrimers with the porcine skin surface. DYNAMICS AND FLUCTUATIONS IN BIOMEDICAL PHOTONICS IX (vol. 8580). link> doi>
  • Moss GP, Kyriacou T, Wilkinson SC, Judd A, Gullick DR. 2012. Modelling of absorption across skin and silicone membranes using non-linear auto-regressive moving average with exogenous input (NARMAX) methods. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (vol. 34, p. 377). link>
  • Judd A, Heylings J, Wan K-W, Moss G. 2012. Nanomaterials for the advancement of infection control. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (vol. 34, p. 372). link>
  • Moss GP, Shah AJ, Judd A, Adams RG, Davey N, Wilkinson SC, Pugh WJ, Sun Y. 2012. The application of machine learning methods to identify and classify potential transdermal enhancers. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (vol. 34, p. 377). link>
  • Chika A, Gard PR, Ingram MJ, Moss GP. 2010. Synthesis and ACE-inhibitory potency of captopril branched chain ester prodrugs. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 62, pp. 1374-1375). link>
  • Araim Z, Ingram MJ, Moss GP, Patel B, Santin M, Meikle S. 2010. Synthesis of NO-releasing peptides and peptoids for stent coating. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 62, p. 1381). link>
  • Lam LT, Sun Y, Davey N, Adams R, Prapodopolou M, Brown MB, Moss GP. 2010. The appication of feature selection to the development of Gaussian Process models for percutaneous absorption. J Pharmacy & Pharmacology. doi>
  • Anjum K, Staf K, Mistry T, Stair J, Moss GP. 2010. The effect of depilation on the percutaneous absorption of aluminium from antiperspirant products. 12th International perspectives in percutameous penetration.
  • Mistry T, Staff K, Anjum K, Owen J, Stair JL, Moss GP. 2010. The effect of occlusion on the percutaneous absorption of aluminium from antiperspirant products. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 62, p. 799). link>
  • Palmer IA, Jones SA, Murnane D, Traynor MJ, Moss GP, Brown MB. 2010. Transiently supersaturated solutions from the dissolution of amorphous powders for topical drug delivery. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 62, p. 795). link>
  • Gullick DR, Moss GP, Cox PA, Ingram MJ, Pugh WJ. 2010. Characteristisation of the drug release of a novel captopril prodrug from a matrix-type patch device. La Grande Mott, France: 11th International Perspectives in Percutaneous Penetration.
  • Palmer IA, Brown MB, Jones SA, Moss GP, Traynor MJ. 2010. Novel powder formulation for toical delivery of micronazole nitrate and clotrimazole. La Grande Mott, France: 11th International Perspectives in Percutaneous Penetration.
  • Shali S, Staff K, Moss GP. 2010. Novel venlafaxine prodrugs for enhances percutaneous absorption. Joint meeting: 10th Annual Meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium.
  • Sun Y, Lam LT, Moss G, Prapopoulou M, Adams R, Davey N, Gray D, Brown M, IEEE. 2010. Predicting Drug Absorption Rates Through Human Skin. 2010 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS IJCNN 2010. link>
  • Lam LT, Brown MB, Davey N, Pugh WJ, Sun Y, Moss GP. 2010. The application of machine learning and feature selection methods to the prediction of percutaneous absorption. 12th International perspectives in Percutaneous Penetration.
  • Gullick DR, Cox PA, Pugh WJ, Moss GP. 2010. Variation of predicted permeability: a comparison of quantitative models for skin absorption. Versailles, France: Joint Meeting: 10th Annual Meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium.
  • Lam LT, Bryan S, Davey N, Pugh WJ, Traynor MJ, Sun Y, Moss GP. 2009. Machine learning on barrier function of mammalian skin. Waterville Valley, NH: 11th Gordon Research conference on barrier function of mammalian skin.
  • Lam LT, Brown MB, Prapodopolou M, Davey N, Sun Y, Moss GP. 2009. On the utility of machine learning methods to quantify percutaneous absorption. Versailles, France: Joint Meeting: 10th Annual eeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium.
  • Palmer IA, Brown MB, Jones SA, Murnane D, Moss GP, Traynor MJ. 2009. The effect of amorphouis ad crystalline forms of clotrimazole for topical drug delivery. Versailles, France: Joint meeting: 10th annual meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium.
  • Gullick DR, Moss GP, Cox PA, Pugh WJ. 2008. A comparison of quantitative models for skin absorption. London: 9th Annual Meeting of Skin Forum.
  • Gullick DR, Moss GP, Ingram MJ, Pugh WJ, Cox PA. 2008. In vitro and in silico ACE-inhibitory activity of metabolically stable captopril ester derivatives for percutaneous absorption. La Grande Mott, France: 11th International Conference: Perspectives in Percutaneous Penetration.
  • Moss GP, Sun Y, Prapodopolou M, Davey N, Brown MB. 2008. Non-prametric Gaussian modelling of skin absorption using machine-learning methods. London: 9th Annual Meeting of Skin Forum.
  • Prapodopolou M, Sun Y, Adams R, Davey N, Brown MB, Moss GP. 2008. Prediction of skin penetration using machine learning methods. La Grande Mott, France: 11th International Perspectives in Percutaneoud Penetration.
  • Sun Y, Moss GP, Prapodopolou M, Davey N, Adams R, Brown MB. 2008. Predictions of skin penetration using machine learning methods. In . Giannotti.F, F. Gunopulos, F;Z. Turini, N;W. Ramakrishnan & . X.D;; (Eds.). Pisa, Italy. doi>
  • Gullick DR, Moss GP, Cox PA, Pugh WJ. 2008. Variation of predicted permiability using calculated and experimental log P values: a comparison of quantitative models for skill absorption. Le Grande Mott, France: 11th International Perspectives in Percutaneous Penetration.
  • Gullick DR, Cox PA, Ingram MJ, Moss GP. 2007. Formulation studies for prodrugs of captopril for enhances percutaneous absorption. J Pharmacy & Pharmacology (vol. 59s, p. 11).
  • Moss GP. 2007. Prodrugs for enhances percutaneous absorption - formulation and characterisation of drug-in-adhesive patch formulation. Newport, RI: 10th Gordon Research Conference on Barrier Function of Mammalian Skin.
  • Gullick DR, Moss GP, Pugh WI, Cox PA. 2007. Transdermal patch formulation and diffusion studies for captopril ethyl ester prodrug. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 59, p. A11). link>
  • Moss GP, Gullick DR, Cox PA, Pugh WJ. 2006. A comparison of predicted and experimentally measured descriptors in QSPRs. J Pharmacy & Pharmacology (vol. 58s, p. 104).
  • Moss GP, Gullick DR, Cox PA, Pugh WJ. 2006. A comparison of predicted and experimentally measured descriptors in QSPRs. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 58, p. A10). link>
  • Gullick DR, Cox PA, Moss GP, Pugh WJ. 2006. Captopril prodrugs for transclermal delivery: docking and metabolism with CYP4502c1, RNase, and acetylcholinesterase. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 58, p. A33). link>
  • Gullick DR, Cox PA, Moss GP, Pugh WJ. 2006. Captopril prodrugs for transdermal delivery: docking and metabolism with CYP450cl, RNase, and acetylcholinesterase. J Pharmacy & Pharmacology (vol. 58s, p. 17).
  • Ingram MJ, Moss GP, Gullick DR. 2006. Synthesis and ACE-inhibitory activity of a captopril nitroxoxyethylamide a novel hybrid prodrug of captopril and itramine. J Pharmacy & Pharmacology (vol. 58s, p. 85).
  • Ingram MJ, Gard PR, Balogun T, McCormack C, Hoey K, Moss GP, Gullick DR. 2006. Synthesis and ACE-inhibitory activity of a captopril nitroxoxyethylamide a novel hybrid prodrug of captopril and itramine. JOURNAL OF PHARMACY AND PHARMACOLOGY (vol. 58, p. A85). link>
  • Ingram MJ, Gard P, Asamoah N, Moss GP, Gullick DR. 2005. ACE-inhibitory activity of a captopril propyl ester prodrug. J Pharmacy & Pharmacology (vol. 57s, p. 79).
  • Moss GP, Gullick DR, Pugh WJ. 2005. Do QSPR models accurately reflect percutraneous absorption?. J Pharmacy & Pharmacology (vol. 57s, p. 18).
  • Gullick DR, Cox PA, Moss GP, Pugh WJ. 2005. In vitro metabolism of captopril ester prodrugs: experimental and novel molecular modelling approaches. J Pharmacy & Pharmacology (vol. 57s, p. 41).
  • Moss GP, Gullick DR, Ingram MJ, Gard P, Patel N. 2004. ACE-inhibitory activity of captopril methyl ester prodrug. Portsmouth, UK.
  • Johnson S, Heard CM, Moss GP. 2004. Development of a drug-in-adhesive patch containing extract of Paullinia Cupana. Portsmouth, UK.
  • Gullick DR, Moss GP, Ingram MJ, Alexander C, Smart JD, Pugh WJ. 2004. The in vitro metabolism os captopril carboxy ester prodrugs. La Grande Motte, France: 9th International Conference on Perspectives in Percutaneous Penetration.
  • Gullick DR, Moss GP, Ingram MJ, Alexander C, Smart JD, Pugh WJ. 2004. The in vitro pecutaneous absorption of captopril carboxyl ester prodrugs. 9th Internationa Conference on Perspectives in Percutaneous Penetration.
  • Moss GP, Dibben SD, Gullick DR, Thomas CP, Pugh WJ. 2004. The in vitro percutaneous absorption of aluminium from topical products. Portsmouth, UK.
  • Gullick DR, Moss GP, Ingram MJ, Alexander C, Smart JD, Pugh WJ. 2004. The in vitro percutaneous absorption of captopril carboxyl ester prodrugs: comparison of fresh vs. frozen skin for a series of carboxyl n-esters. Portsmouth, UK.
  • Gullick DR, Moss GP, Ingram MJ, Alexander C, Smart JD, Pugh WJ. 2004. The metabolism of captopril carboxyl ester prodrugs: development of in vitro and ex vivo methods. Portsmouth, Uk.
  • Moss GP, Gullick DR, Ingram MJ, Alexander C, Smart JD, Pugh WJ. 2003. Synthesis and Characterisation of captopril carboxylate-ester prodrugs. J Pharmacy & Pharmacology (vol. 56S, p. 42).

Teaching covers aspects of pharmaceutics and drug delivery on both the BSc (Pharmaceutical Science, Technology and Business) and MPharm (Pharmacy) programmes at all levels of both courses.

·           Chartered Chemist and Member of the Royal Society of Chemistry, since March 1996.

·           Fellow of the Higher Education Academy, since July 2004.

·           Founding member and committee member of the EPSRC Drug Delivery Research Network.

·           Chairman (2004–2006), treasurer (2004–2005) and committee member (2003 – current date) of the Skin Forum Group (a focus group of the Academy of Pharmaceutical Sciences, initially funded by EPSRC).

·           Representative of the EPSRC Skin Forum on the All Party Parliamentary Group on Skin, 2008 – 2010.

·           Member of the Editorial Board of the International Journal of Cosmetic Sciences and Journal of Pharmacy and Pharmacology; Editor for Journal of Pharmacy and Pharmacology (Special Themed Edition on Recent Advances in Percutaneous Absorption, published June 2010).

·           Member of the International Steering Committee Member, Handbook of Pharmaceutical Excipients.

·           Member of the Pharmaceutical Sciences Group of the Royal Pharmaceutical Society of Great Britain.

·           Member of the Industrial Pharmacy Group of the Royal Pharmaceutical Society of Great Britain.

·           Member of the Academic Pharmacy Group of the Royal Pharmaceutical Society of Great Britain.

·           Member of the Academy of Pharmaceutical Sciences.

·           External examiner for:

- M.Pharm. programme at the Kingston University School of Pharmacy (2013 - 2017)

- OSPAP programme at the Kingston University School of Pharmacy (2014 - 2017) 

- M.Pharm. programme at the University of Ulster School of Pharmacy (2009 - 2013)

- M.Res. programme at the University of Brighton School of Pharmacy (2007 - 2012)

- approximately fifteen PhD candidates at UK Schools of Pharmacy

§  Chartered Chemist and Member of the Royal Society of Chemistry, since March 1996.

§  Fellow of the Higher Education Academy, July 2004.

§  Founding member and current committee member of the EPSRC Drug Delivery Research Network.

§  Chairman (2004–2006), treasurer (2004–2005) and committee member (2003 – current date) of the Skin Forum Group (a focus group of the Academy of Pharmaceutical Sciences, initially funded by EPSRC).

§  Representative of the EPSRC Skin Forum on the All Party Parliamentary Group on Skin, 2008 – 2010.

§  Member of the Editorial Board of the International Journal of Cosmetic Sciences and Journal of Pharmacy and Pharmacology; Editor for Journal of Pharmacy and Pharmacology (Special Themed Edition on Recent Advances in Percutaneous Absorption, published June 2010).

§  Member of the International Steering Committee Member, Handbook of Pharmaceutical Excipients.

§  Member of the Pharmaceutical Sciences Group of the Royal Pharmaceutical Society of Great Britain.

§  Member of the Industrial Pharmacy Group of the Royal Pharmaceutical Society of Great Britain.

§  Member of the Academic Pharmacy Group of the Royal Pharmaceutical Society of Great Britain.

§  Member of the Academy of Pharmaceutical Sciences.

§  External examiner for the M.Pharm. programme at the University of Ulster and the M.Res. programme at the University of Brighton Schools of Pharmacy.